Harvard Bioscience (HBIO) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.12% |
| Dec 31, 2025 | -5.19% |
| Sep 30, 2025 | -3.05% |
| Jun 30, 2025 | -2.58% |
| Mar 31, 2025 | -1.74% |
| Dec 31, 2024 | -4.54% |
| Sep 30, 2024 | -4.33% |
| Jun 30, 2024 | -4.83% |
| Mar 31, 2024 | -2.77% |
| Dec 31, 2023 | -3.62% |
| Sep 30, 2023 | -2.40% |
| Jun 30, 2023 | -1.82% |
| Mar 31, 2023 | 2.30% |
| Dec 31, 2022 | 5.60% |
| Sep 30, 2022 | 7.54% |
| Jun 30, 2022 | 9.03% |
| Mar 31, 2022 | 9.73% |
| Dec 31, 2021 | 4.59% |
| Sep 30, 2021 | 3.47% |
| Jun 30, 2021 | 2.24% |
| Mar 31, 2021 | 0.02% |
| Dec 31, 2020 | 1.78% |
| Sep 30, 2020 | -1.35% |
| Jun 30, 2020 | -4.14% |
| Mar 31, 2020 | -1.60% |
| Dec 31, 2019 | 0.40% |
| Sep 30, 2019 | 1.50% |
| Jun 30, 2019 | 1.88% |
| Mar 31, 2019 | 1.72% |
| Dec 31, 2018 | 3.98% |
| Sep 30, 2018 | 2.64% |
| Jun 30, 2018 | 3.85% |
| Mar 31, 2018 | 0.51% |
| Dec 31, 2017 | -5.19% |
| Sep 30, 2017 | -6.44% |
| Jun 30, 2017 | -7.83% |
| Mar 31, 2017 | -8.58% |
| Dec 31, 2016 | -1.87% |
| Sep 30, 2016 | -1.06% |
| Jun 30, 2016 | -0.75% |
| Mar 31, 2016 | 0.49% |
| Dec 31, 2015 | -0.79% |
| Sep 30, 2015 | -0.55% |
| Jun 30, 2015 | 2.14% |